OLEMA PHARMACEUTICALS INC. - COMMON STOCK

Olema Oncology Reports Second Quarter 2022 Financial Results and Provides Corporate Update

09 8 2022 15:35:00 提供 Nasdaq GlobeNewswire

Olema Oncology Advances OP-1250 into Phase 2 Monotherapy Expansion in Patients with ER+/HER2- Advanced Breast Cancer

09 8 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Canaccord Genuity 42nd Annual Growth Conference

04 8 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 8 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Receives FDA Fast Track Designation for OP-1250 for the Treatment of ER+ / HER2- Metastatic Breast Cancer

21 7 2022 06:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

05 7 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Provides Clinical Update Reflecting Strong Progress Across OP-1250 Development Program

09 6 2022 06:35:00 提供 Nasdaq GlobeNewswire

Olema Oncology and Aurigene Announce Exclusive Collaboration and License Agreement to Discover and Develop Novel Cancer Therapies

09 6 2022 06:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 6 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Jefferies Healthcare Conference

24 5 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports First Quarter 2022 Financial Results and Provides Corporate Update

09 5 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 5 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

18 4 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

04 4 2022 06:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Announces Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2022

08 3 2022 15:35:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

28 2 2022 15:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at Cowen 42nd Annual Health Care Conference

22 2 2022 06:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

03 2 2022 16:00:00 提供 Nasdaq GlobeNewswire

Olema Oncology Appoints Naseem Zojwalla, M.D., as Chief Medical Officer

31 1 2022 06:30:00 提供 Nasdaq GlobeNewswire

Olema Oncology to Present at 40th Annual J.P. Morgan Healthcare Conference

04 1 2022 06:30:00 提供 Nasdaq GlobeNewswire